Dartmouth-Hitchcock Medical Center
583
62
80
380
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
15.1%
88 terminated/withdrawn out of 583 trials
81.2%
-5.3% vs industry average
8%
44 trials in Phase 3/4
42%
161 of 380 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (583)
Restoration of Thumb Strength and Function in Basal Joint Arthritis: A Comparative Effectiveness Trial (RESTART)
Role: lead
24GUT540 : Meeting of Breast Cancer Patients and Pathologists
Role: lead
HOBSCOTCH-YOUTH and Young Adults
Role: lead
ICG Fluorescence Imaging in Open Fracture Trauma Patients
Role: lead
Advancing Antimicrobial Photodynamic Therapy to Prevent Infection in Osseointegrated Prosthesis Patients
Role: lead
Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release
Role: lead
Pilot Trial of the Move Healthier Group
Role: lead
Plan and Protect: Safety Planning for Teens in Rural Emergency Departments
Role: lead
Implementation Intention Planning Guide for FIT Colon Cancer Screening
Role: lead
Internet Based Psychological Support
Role: lead
The Agenda-Setting for Kidney Disease Open Pilot Trial
Role: lead
OCT in Open Fracture and Infected Fracture
Role: lead
MCI Speech in Noise
Role: lead
ASKids! Inpatient Agenda-Setting Study for Hospitalized Children With Medical Complexity
Role: lead
Comparative Effectiveness of IIMR Versus CDSMP
Role: lead
Magnetic Resonance Elastography in Hydrocephalus
Role: lead
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
Role: lead
Bioimpedance for Ortho Trauma
Role: lead
Treatment of UC With Novel Therapeutics
Role: collaborator
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
Role: lead